Skip to Main Content

Pharma Services Due Diligence: Identifying the Commercial Factors Impacting a Successful Private Equity Transaction

White Papers|

By Ryan Coe, Ph.D., Matt Haynes, Ph.D.

Maximizing return on invested capital (ROIC) for private equity-owned contract research, development, manufacturing, and services organizations (CXO) certainly requires strong business fundamentals – buy-side confidence in the underlying assets will make or break a transaction. Learn more.

Pharma Services Due Diligence: Identifying the Commercial Factors Impacting a Successful Private Equity Transaction

Please submit the form below to view this resource.

Maximize value across the product and patient journeys. Find out how.